Meilleure Health International Industry Group Limited

SEHK:2327 Stock Report

Market Cap: HK$593.4m

Meilleure Health International Industry Group Management

Management criteria checks 4/4

Meilleure Health International Industry Group's CEO is Wen Chuan Zhou, appointed in Sep 2013, has a tenure of 10.67 years. total yearly compensation is HK$987.00K, comprised of 121.6% salary and -21.6% bonuses, including company stock and options. directly owns 0.78% of the company’s shares, worth HK$4.63M. The average tenure of the management team and the board of directors is 4.9 years and 8.6 years respectively.

Key information

Wen Chuan Zhou

Chief executive officer

HK$987.0k

Total compensation

CEO salary percentage121.6%
CEO tenure10.7yrs
CEO ownership0.8%
Management average tenure4.9yrs
Board average tenure8.6yrs

Recent management updates

Recent updates

Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality

Apr 04
Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality

Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%

Feb 28
Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%

Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)

Jan 23
Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)

Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down

Aug 17
Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down

Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)

Oct 18
Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)

Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?

Sep 06
Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?

Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist

Jul 12
Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist

Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?

Sep 09
Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?

Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue

May 15
Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue

Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly

Apr 18
Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly

Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?

Jan 29
Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?

Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay

Dec 08
Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay

CEO Compensation Analysis

How has Wen Chuan Zhou's remuneration changed compared to Meilleure Health International Industry Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

HK$41m

Sep 30 2023n/an/a

HK$33m

Jun 30 2023n/an/a

HK$25m

Mar 31 2023n/an/a

HK$22m

Dec 31 2022HK$987kHK$1m

HK$18m

Sep 30 2022n/an/a

HK$23m

Jun 30 2022n/an/a

HK$28m

Mar 31 2022n/an/a

HK$44m

Dec 31 2021HK$2mHK$1m

HK$60m

Sep 30 2021n/an/a

HK$72m

Jun 30 2021n/an/a

HK$84m

Mar 31 2021n/an/a

HK$84m

Dec 31 2020HK$2mHK$1m

HK$83m

Sep 30 2020n/an/a

HK$32m

Jun 30 2020n/an/a

-HK$19m

Mar 31 2020n/an/a

-HK$19m

Dec 31 2019HK$800kHK$800k

-HK$20m

Sep 30 2019n/an/a

HK$31m

Jun 30 2019n/an/a

HK$83m

Mar 31 2019n/an/a

HK$82m

Dec 31 2018HK$540kHK$540k

HK$81m

Sep 30 2018n/an/a

HK$81m

Jun 30 2018n/an/a

HK$81m

Mar 31 2018n/an/a

HK$81m

Dec 31 2017HK$540kHK$540k

HK$80m

Compensation vs Market: Wen Chuan's total compensation ($USD126.20K) is below average for companies of similar size in the Hong Kong market ($USD233.89K).

Compensation vs Earnings: Wen Chuan's compensation has been consistent with company performance over the past year.


CEO

Wen Chuan Zhou (40 yo)

10.7yrs

Tenure

HK$987,000

Compensation

Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of Meilleure Health International Industry Group Limited (formerly known as U-Home Group Holdings Limited) since September 23,...


Leadership Team

NamePositionTenureCompensationOwnership
Xuzhou Zhou
Executive Co-Chairman of the Board10.8yrsHK$800.00k32.49%
HK$ 192.8m
Wentao Zeng
Executive Co-Chairman of the Board6.6yrsHK$167.00k1.83%
HK$ 10.9m
Wen Chuan Zhou
Vice Chairman & CEO10.7yrsHK$987.00k0.78%
HK$ 4.6m
Shu Pai Li
CFO & Company Secretary4.8yrsno datano data
Man Chun Chu
Human Resources Managerno datano datano data

4.9yrs

Average Tenure

60yo

Average Age

Experienced Management: 2327's management team is considered experienced (4.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xuzhou Zhou
Executive Co-Chairman of the Board10.8yrsHK$800.00k32.49%
HK$ 192.8m
Wentao Zeng
Executive Co-Chairman of the Board6.6yrsHK$167.00k1.83%
HK$ 10.9m
Wen Chuan Zhou
Vice Chairman & CEO10.8yrsHK$987.00k0.78%
HK$ 4.6m
Chi Wai Chau
Independent Non-Executive Director10.8yrsHK$180.00kno data
Zhenhua Mao
Non-Executive Director8.6yrsHK$180.00kno data
Shi Chen
Independent Non-Executive Directorless than a yearno datano data
Peng Wu
Independent Non-Executive Director5yrsHK$120.00kno data

8.6yrs

Average Tenure

60yo

Average Age

Experienced Board: 2327's board of directors are considered experienced (8.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.